Echo Therapeutics Top Management
Echo Therapeutics employs about 19 people. The company is managed by 6 executives with a total tenure of roughly 45 years, averaging almost 7.0 years of service per executive, having 3.17 employees per reported executive. Evaluation of Echo Therapeutics' management performance can provide insight into the firm performance.
| Scott Hollander CEO CEO and President and Director |
Echo |
Echo Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (359.77) % which means that it has lost $359.77 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.649) %, meaning that it created substantial loss on money invested by shareholders. Echo Therapeutics' management efficiency ratios could be used to measure how well Echo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Echo Therapeutics Workforce Comparison
Echo Therapeutics is one of the top stocks in number of employees category among related companies. The total workforce of Medical Devices industry is currently estimated at about 174,357. Echo Therapeutics adds roughly 19.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
Echo Therapeutics Notable Stakeholders
An Echo Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Echo Therapeutics often face trade-offs trying to please all of them. Echo Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Echo Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Scott Hollander | CEO and President and Director | Profile | |
| Alan Schoenbart | CFO | Profile | |
| Michael Goldberg | Director | Profile | |
| Elazer Edelman | Director | Profile | |
| Christine Olimpio | Director of Investor Relations and Corporate Communications | Profile | |
| Shepard Goldberg | Director | Profile |
Echo Therapeutics Workforce Analysis
Traditionally, organizations such as Echo Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Echo Therapeutics within its industry.Echo Therapeutics Manpower Efficiency
Return on Echo Therapeutics Manpower
| Revenue Per Employee | 269 | |
| Revenue Per Executive | 853 | |
| Net Loss Per Employee | 657.9K | |
| Net Loss Per Executive | 2.1M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Echo Stock
If you are still planning to invest in Echo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Echo Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |